diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/DM2015187-93diaendo-6701Research ArticleХроническая болезнь почекChronic Kidney DiseaseЦистатин С и коллаген IV типа в диагностике хронической болезни почек у больных сахарным диабетом 2 типаCystatin C and collagen type IV in diagnostics of chronic kidney disease in type 2 diabetic patientsКлимонтовВадим ВалерьевичKlimontovVadim Valer'evich

Доктор медицинских наук, заведующий лабораторией эндокринологии, зам. директора по научной работе

MD, PhD, Head of the endocrinology laboratory

klimontov@mail.ruЕременкоНадежда ВалентиновнаEremenkoNadezhda Valentinovna

Врач клинической лабораторной диагностики

MD

slavrom@mail.ruМякинаНаталья ЕвгеньевнаMyakinaNatalya Evgen'evna

Младший научный сотрудник лаборатории эндокринологии

MD, Assistant researcher

nmyakina@list.ruФазуллинаОльга НиколаевнаFazullinaOlga Nikolaevna

Младший научный сотрудник лаборатории эндокринологии

MD, assistant researcher

fazullina@ngs.ruФГБНУ "Научно-исследовательский институт клинической и экспериментальной лимфологии", НовосибирскРоссияInstitute of Clinical and Experimental Lymphology, NovosibirskRussian FederationЛаборатория "ИНВИТРО-СИБИРЬ", г. НовосибирскРоссияLaboratory “INVITRO-SIBERIA”, NovosibirskRussian Federation2015170320151818793Copyright © Климонтов В.В., Еременко Н.В., Мякина Н.Е., Фазуллина О.Н., 20152015Климонтов В.В., Еременко Н.В., Мякина Н.Е., Фазуллина О.Н.Klimontov V.V., Eremenko N.V., Myakina N.E., Fazullina O.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/6701сахарный диабет 2 типахроническая болезнь почекскорость клубочковой фильтрациицистатин Сколлаген IV типаtype 2 diabeteschronic kidney diseaseglomerular filtration ratecystatin Ctype IV collagenРоссийский научный фонд; OOO "Акватест"ReferencesДедов И.И., Шестакова М.В., Александров А.А., и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под редакцией И.И. Дедова, М.В. Шестаковой (6-й выпуск). // Сахарный диабет. – 2013. – №1S – С. 1-121. [Dedov II, Shestakova MV, Aleksandrov AA, et al. Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV (6th edition). Diabetes mellitus. 2013;(1S):1-120.] doi: 10.14341/DM20131S1-121Дедов И.И., Шестакова М.В., Александров А.А., и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под редакцией И.И. Дедова, М.В. Шестаковой (6-й выпуск). // Сахарный диабет. – 2013. – №1S – С. 1-121. [Dedov II, Shestakova MV, Aleksandrov AA, et al. Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV (6th edition). Diabetes mellitus. 2013;(1S):1-120.] doi: 10.14341/DM20131S1-121American. Diabetes Association. Standards of medical care in diabetes - 2014. Diabetes Care 2014;37 Suppl 1:14-80. doi: 10.2337/dc14-S014American. Diabetes Association. Standards of medical care in diabetes - 2014. Diabetes Care 2014;37 Suppl 1:14-80. doi: 10.2337/dc14-S014KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013;3(1):1-150. Available from: http://www.kdigo.org/clinical_practice_guidelines/pdf/CKD/KDIGO_2012_CKD_GL.pdfKDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013;3(1):1-150. Available from: http://www.kdigo.org/clinical_practice_guidelines/pdf/CKD/KDIGO_2012_CKD_GL.pdfВельков В.В. Цистатин С: индикатор скорости клубочковой фильтрации и маркер тяжести сердечно-сосудистых событий. // Лабораторная медицина. – 2011. – №11 – С. 55-59.[ Vel'kov VV. Tsistatin S: indikator skorosti klubochkovoy fil'tratsii i marker tyazhesti serdechno-sosudistykh sobytiy. Laboratornaya meditsina 2011;11:55-59.]Вельков В.В. Цистатин С: индикатор скорости клубочковой фильтрации и маркер тяжести сердечно-сосудистых событий. // Лабораторная медицина. – 2011. – №11 – С. 55-59.[ Vel'kov VV. Tsistatin S: indikator skorosti klubochkovoy fil'tratsii i marker tyazhesti serdechno-sosudistykh sobytiy. Laboratornaya meditsina 2011;11:55-59.]Conti M, Moutereau S, Zater M, et al. Urinary cystatin C as a specific marker of tubular dysfunction. Clinical Chemical Laboratory Medicine 2006;44(3):288-291. doi: 10.1515/CCLM.2006.050Conti M, Moutereau S, Zater M, et al. Urinary cystatin C as a specific marker of tubular dysfunction. Clinical Chemical Laboratory Medicine 2006;44(3):288-291. doi: 10.1515/CCLM.2006.050Köttgen A, Selvin E, Stevens LA, et al. Serum Cystatin C in the United States: The Third National Health and Nutrition Examination Survey (NHANES III). American Journal of Kidney Diseases 2008;51(3):385-394. doi: 10.1053/j.ajkd.2007.11.019Köttgen A, Selvin E, Stevens LA, et al. Serum Cystatin C in the United States: The Third National Health and Nutrition Examination Survey (NHANES III). American Journal of Kidney Diseases 2008;51(3):385-394. doi: 10.1053/j.ajkd.2007.11.019Chudleigh RA, Ollerton RL, Dunseath G, et al. Use of cystatin C-based estimations of glomerular filtration rate in patients with type 2 diabetes. Diabetologia 2009;52(7):1274-1278. doi: 10.1007/s00125-009-1379-7Chudleigh RA, Ollerton RL, Dunseath G, et al. Use of cystatin C-based estimations of glomerular filtration rate in patients with type 2 diabetes. Diabetologia 2009;52(7):1274-1278. doi: 10.1007/s00125-009-1379-7Bevc S, Hojs R, Ekart R, et al. Simple Cystatin C Formula for Estimation of Glomerular Filtration Rate in Overweight Patients with Diabetes Mellitus Type 2 and Chronic Kidney Disease. Experimental Diabetes Research 2012;2012:179849. doi: 10.1155/2012/179849Bevc S, Hojs R, Ekart R, et al. Simple Cystatin C Formula for Estimation of Glomerular Filtration Rate in Overweight Patients with Diabetes Mellitus Type 2 and Chronic Kidney Disease. Experimental Diabetes Research 2012;2012:179849. doi: 10.1155/2012/179849Fan L, Inker LA, Rossert J, et al. Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test. Nephrology Dialysis Transplantation 2014;29(6):1195-1203. doi: 10.1093/ndt/gft509Fan L, Inker LA, Rossert J, et al. Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test. Nephrology Dialysis Transplantation 2014;29(6):1195-1203. doi: 10.1093/ndt/gft509Okonogi H, Nishimura M, Utsunomiya Y, et al. Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus. Clin Nephrol 2001;55(5):357-364. PubMed PMID: 11393380Okonogi H, Nishimura M, Utsunomiya Y, et al. Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus. Clin Nephrol 2001;55(5):357-364. PubMed PMID: 11393380Бондарь И.А., Климонтов В.В., Парфентьева Е.М. и др. Мочевая экскреция коллагена IV типа - ранний маркер фиброзирования почек при сахарном диабете. // Сахарный диабет. – 2011. – №4 – С. 29-31. [Bondar' IA, Klimontov VV, Parfent'eva EM, et al. Urinary excretion of type IV collagen as an early marker of renal fibrosis in patients with diabetes mellitus. Diabetes mellitus. 2011;(4):29-31.] doi: 10.14341/2072-0351-5813Бондарь И.А., Климонтов В.В., Парфентьева Е.М. и др. Мочевая экскреция коллагена IV типа - ранний маркер фиброзирования почек при сахарном диабете. // Сахарный диабет. – 2011. – №4 – С. 29-31. [Bondar' IA, Klimontov VV, Parfent'eva EM, et al. Urinary excretion of type IV collagen as an early marker of renal fibrosis in patients with diabetes mellitus. Diabetes mellitus. 2011;(4):29-31.] doi: 10.14341/2072-0351-5813Бондарь И.А., Климонтов В.В. Ранние маркеры диабетической нефропатии. // Клиническая нефрология. – 2010. – №2 – С. 60-65. [Bondar' IA, Klimontov VV. Early markers of diabetic nephropathy. Clinical Nephrology 2010;(2):60-65.]Бондарь И.А., Климонтов В.В. Ранние маркеры диабетической нефропатии. // Клиническая нефрология. – 2010. – №2 – С. 60-65. [Bondar' IA, Klimontov VV. Early markers of diabetic nephropathy. Clinical Nephrology 2010;(2):60-65.]Conti M, Moutereau S, Esmilaire L, et al. Should kidney tubular markers be adjusted for urine creatinine? The example of urinary cystatin C. Clinical Chemistry and Laboratory Medicine 2009;47(12):1553-1556. doi: 10.1515/CCLM.2009.341Conti M, Moutereau S, Esmilaire L, et al. Should kidney tubular markers be adjusted for urine creatinine? The example of urinary cystatin C. Clinical Chemistry and Laboratory Medicine 2009;47(12):1553-1556. doi: 10.1515/CCLM.2009.341Selvin E, Juraschek SP, Eckfeldt J, et al. Within-Person Variability in Kidney Measures. American Journal of Kidney Diseases 2013;61(5):716-722. doi: 10.1053/j.ajkd.2012.11.048Selvin E, Juraschek SP, Eckfeldt J, et al. Within-Person Variability in Kidney Measures. American Journal of Kidney Diseases 2013;61(5):716-722. doi: 10.1053/j.ajkd.2012.11.048Naour N, Fellahi S, Renucci J, et al. Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. Obesity (Silver Spring) 2009;17(12):2121-2126. doi: 10.1038/oby.2009.96Naour N, Fellahi S, Renucci J, et al. Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. Obesity (Silver Spring) 2009;17(12):2121-2126. doi: 10.1038/oby.2009.96Reutens AT, Bonnet F, Lantieri O, et al. The association between cystatin C and incident type 2 diabetes is related to central adiposity. Nephrology Dialysis Transplantation 2013;28(7):1820-1829. doi: 10.1093/ndt/gfs561Reutens AT, Bonnet F, Lantieri O, et al. The association between cystatin C and incident type 2 diabetes is related to central adiposity. Nephrology Dialysis Transplantation 2013;28(7):1820-1829. doi: 10.1093/ndt/gfs561Herget-Rosenthal S, van Wijk JAE, Bröcker-Preuss M, Bökenkamp A. Increased urinary cystatin C reflects structural and functional renal tubular impairment independent of glomerular filtration rate. Clinical Biochemistry 2007;40(13-14):946-951. doi: 10.1016/j.clinbiochem.2007.04.013Herget-Rosenthal S, van Wijk JAE, Bröcker-Preuss M, Bökenkamp A. Increased urinary cystatin C reflects structural and functional renal tubular impairment independent of glomerular filtration rate. Clinical Biochemistry 2007;40(13-14):946-951. doi: 10.1016/j.clinbiochem.2007.04.013Furumatsu Y, Nagasawa Y, Shoji T, et al. Urinary type IV collagen in nondiabetic kidney disease. Nephron Clin Pract 2010;117(2):160-166. doi: 10.1159/000319794Furumatsu Y, Nagasawa Y, Shoji T, et al. Urinary type IV collagen in nondiabetic kidney disease. Nephron Clin Pract 2010;117(2):160-166. doi: 10.1159/000319794Cohen MP, Lautenslager GT, Shearman CW. Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice. Metabolism 2001;50(12):1435-1440. doi: 10.1053/meta.2001.28074Cohen MP, Lautenslager GT, Shearman CW. Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice. Metabolism 2001;50(12):1435-1440. doi: 10.1053/meta.2001.28074Araki S, Haneda M, Koya D, et al. Association Between Urinary Type IV Collagen Level and Deterioration of Renal Function in Type 2 Diabetic Patients Without Overt Proteinuria. Diabetes Care 2010;33(8):1805-1810. doi: 10.2337/dc10-0199Araki S, Haneda M, Koya D, et al. Association Between Urinary Type IV Collagen Level and Deterioration of Renal Function in Type 2 Diabetic Patients Without Overt Proteinuria. Diabetes Care 2010;33(8):1805-1810. doi: 10.2337/dc10-0199

The authors declare that there are no conflicts of interest present.